Testosterone Undecanoate (TU)
Alternative Name: TU; Aveed
Description: Testosterone undecanoate (TU) is manufactured by Bayer Health Care and the injectable formulation was recently approved by the FDA (Aveed) to be marketed by Endo Pharmaceuticals for treatment of hypogonadism. It is not approved for use as a contraceptive agent.
Product Details
Regimen:
Dose: 500 mg
Active Pharmaceutical Ingredient (API):
Inactive material: tea seed oil
Status Details
Developer: ,
Status Details: - A phase III trial was completed in China in 2008 by the National Research Institute for Family Planning.
- In the Chinese study, TU was evaluated as a stand-alone contraceptive, but it is unlikely that further development will happen with it as as a single API product, but would rather be developed with a progestin added.
- A phase III trial was completed in China in 2008 by the National Research Institute for Family Planning.
- In the Chinese study, TU was evaluated as a stand-alone contraceptive, but it is unlikely that further development will happen with it as as a single API product, but would rather be developed with a progestin added.
Additional Information
References: Gu Y, Liang X, et al. (2009) Multicenter contraceptive efficacy trial of injectable testosterone undecanoate in Chinese men. J Clin Endocrinol Metab. 94(6): 1910-5.
Gu Y, Liang X, et al. (2009) Multicenter contraceptive efficacy trial of injectable testosterone undecanoate in Chinese men. J Clin Endocrinol Metab. 94(6): 1910-5.
Footnotes: - See also entries for TU with a progestin, such as TU + NET-EN
- See also entries for TU with a progestin, such as TU + NET-EN